STOCK TITAN

Satellos Bioscience Stock Price, News & Analysis

MSLE NASDAQ

Company Description

Satellos Bioscience (NASDAQ: MSLE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $135.4M, ranking #4,864 among all listed U.S. companies by market cap.

MSLE stock has declined 36.3% over the past year. Shares last traded at $7.36.

This page provides a comprehensive overview of MSLE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$7.31
-0.68%
0.05
Last updated: April 14, 2026 at 15:59
-36.27%
Performance 1 year
$135.4M

Satellos Bioscience (MSLE) stock last traded at $7.36, down 0.68% from the previous close. Over the past 12 months, the stock has lost 36.3%. At a market capitalization of $135.4M, MSLE is classified as a micro-cap stock with approximately 20.6M shares outstanding.

Latest News

Satellos Bioscience has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 1 article coincided with positive price movement and 8 with negative movement. Key topics include earnings, conferences, clinical trial, offering. View all MSLE news →

SEC Filings

Satellos Bioscience has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form 40-F. The most recent filing was submitted on April 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MSLE SEC filings →

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

APR
21
April 21, 2026 - April 22, 2026 Marketing

Investor one-on-one meetings

CEO Frank Gleeson and CFO Liz Williams holding one-on-one investor meetings at Toronto conference Apr 21-22
APR
21
April 21, 2026 Marketing

CEO presentation

Bloom Burton Healthcare Investor Conference in Toronto; live webcast & replay on company's Events & Presentations page

Satellos Bioscience has 2 upcoming scheduled events. The next event, "Investor one-on-one meetings", is scheduled for April 21, 2026 (in 6 days). Investors can track these dates to stay informed about potential catalysts that may affect the MSLE stock price.

Short Interest History

Last 12 Months

Short interest in Satellos Bioscience (MSLE) currently stands at 69.5 thousand shares, up 1.8% from the previous reporting period, representing 0.4% of the float. Over the past 12 months, short interest has increased by 939.6%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Satellos Bioscience (MSLE) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

MSLE Company Profile & Sector Positioning

Satellos Bioscience (MSLE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #159 among all tracked companies.

Frequently Asked Questions

What is the current stock price of Satellos Bioscience (MSLE)?

The current stock price of Satellos Bioscience (MSLE) is $7.36 as of April 13, 2026.

What is the market cap of Satellos Bioscience (MSLE)?

The market cap of Satellos Bioscience (MSLE) is approximately 135.4M. Learn more about what market capitalization means .